⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMRX News
Amneal Pharmaceuticals, Inc. Class A Common Stock
Amneal to Report First Quarter 2026 Results on May 1, 2026
globenewswire.com
AMRX
Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month
globenewswire.com
AMRX
Doxorubicin Market Outlook 2026-2030 & 2035: Predicted to Surge to $2 Billion by 2030, Bolstered by Expanding Access to Cancer Care
globenewswire.com
PFE
JNJ
BAX
AMRX
American Parkinson Disease Association Kicks Off Awareness Month with Launch of New Public Service Announcement
prnewswire.com
AMRX
Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry
globenewswire.com
PFE
NVS
EXEL
BMY
AMRX
JNJ
Pombiliti (Amicus Therapeutics) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, Forecasts
globenewswire.com
AMRX
Amneal to Participate in Upcoming Investor Conference
globenewswire.com
AMRX
Global Digital Biomarkers Market to Reach USD 15.60 Billion by 2030 | MarketsandMarkets™
globenewswire.com
AMRX
ALAB
ALTASCIENCES GIBT DIE ERNENNUNG VON CHRIS PERKIN ZUM MITGLIED DES VERWALTUNGSRATS UND VON MARIE-HÉLÈNE RAIGNEAU ZUR CHIEF EXECUTIVE OFFICER BEKANNT
businesswire.com
AMRX
ALTASCIENCES GIBT DIE ERNENNUNG VON CHRIS PERKIN ZUM MITGLIED DES VERWALTUNGSRATS UND VON MARIE-HÉLÈNE RAIGNEAU ZUR CHIEF EXECUTIVE OFFICER BEKANNT
businesswire.com
AMRX